Abstracts tagged "Ethnic studies"

Abstract Number: 71 • 2014 ACR/ARHP Annual Meeting
Prevalence of Pain Reporting in Different Ethnic Groups in the UK: Results from a Large Biobank
Marcus Beasley¹, Gareth T. Jones¹, Tatiana Macfarlane² and Gary J. Macfarlane¹, ¹Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, ²Dental School, University of Aberdeen, Aberdeen, United Kingdom
Background/Purpose: Very large epidemiological studies designed to investigate genetic and environmental influences on disease, known as ‘biobanks' can be used to look at associations between…
Abstract Number: 2956 • 2014 ACR/ARHP Annual Meeting
Identification of Autoimmune Functional Variants Under Positive Selection in the Gullah African American Population of South Carolina
Paula S. Ramos¹, Satria Sajuthi², Jasmin Divers², Yiqi Huang³, Uma Nayak⁴, Wei-Min Chen⁴, Kelly J. Hunt⁵, Diane L. Kamen⁶, Gary S. Gilkeson⁶, Jyotika K. Fernandes⁷, Ida J. Spruill⁷, W. Timothy Garvey⁸, Michèle M. Sale³ and Carl D. Langefeld², ¹Department of Medicine, Medical University of South Carolina, Charleston, SC, ²Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, ³Department of Medicine and Center for Public Health Genomics, University of Virginia, Charlottesville, VA, ⁴Public Health Sciences, University of Virginia, Charlottesville, VA, ⁵Public Health Sciences, Medical University of South Carolina, Charleston, SC, ⁶Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC, ⁷Medical University of South Carolina, Charleston, SC, ⁸Department of Nutrition Sciences and Birmingham VA Medical Center, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose The reasons for the ethnic disparities in rheumatologic and autoimmune diseases (ADs) are largely unknown. We posit that population-specific selection influencing the allele frequencies…
Abstract Number: 2629 • 2014 ACR/ARHP Annual Meeting
Childhood-Onset and Adult-Onset Systemic Lupus Erythematosus: Distinctions in an Underserved Ethnic Minority Cohort
Rebekah Neal¹, Kimberly DeQuattro², Elizabeth C. Ortiz¹ and Francisco P. Quismorio Jr. ³, ¹Rheumatology, University of Southern California, Los Angeles, CA, ²LAC+USC Medical Center, Los Angeles, CA, ³Div of Rheum & Immun, Keck School of Medicine, University of Southern California, Los Angeles, CA
Background/Purpose: Previous studies suggest differences between childhood-onset SLE (cSLE) and adult onset SLE (aSLE). Whereas the prevalence of nephritis, neuropsychiatric, dermatologic, and hematologic manifestations are…
Abstract Number: 1663 • 2014 ACR/ARHP Annual Meeting
Influence of Ethnicity on Efficacy of Current Immunosuppressive Protocols in Proliferative Lupus Nephritis
Angela Pakozdi¹, Ravindra Rajakariar², Michael Sheaff³ and Dev Pyne¹, ¹Rheumatology, Barts Health NHS Trust, London, United Kingdom, ²Renal Medicine, Barts Health NHS Trust, London, United Kingdom, ³Histopathology, Barts Health NHS Trust, London, United Kingdom
Background/Purpose Lupus nephritis (LN) is a major complication of systemic lupus erythematous (SLE) and prevalence is estimated to be 50-60%. Recently, variable responses to induction…
Abstract Number: 1645 • 2014 ACR/ARHP Annual Meeting
Interferon Gene Signature Expression and Serological Differences in Japanese and Non-Japanese SLE Patients
Hitoshi Kohsaka¹, Kosuke Kotani², Tomonori Ishii³, Tomoya Miyamura⁴, Masato Okada⁵, Toshihiko Aranishi², R. Maciuca⁶, William P. Kennedy⁶ and Junko Ohata², ¹Department of Rheumatology, Graduate School of Medical and Dental Sciences,, Tokyo Medical and Dental University (TMDU), Tokyo, Japan, ²Chugai Pharmaceutical co., ltd, Tokyo, Japan, ³Department of Hematology and Rheumatology, Tohoku University, Sendai, Japan, ⁴Department of Internal Medicine and Rheumatology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan, ⁵Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan, ⁶Genentech, Inc, South San Francisco, CA
Background/Purpose: Elevated expression of interferon(IFN)-regulated genes in peripheral blood cells has been reported in systemic lupus erythematosus (SLE) patients and is known as the IFN…
Abstract Number: 2157 • 2013 ACR/ARHP Annual Meeting
Understanding Differences Between Black and White Patients’ Reactions to New Treatment
Liana Fraenkel¹, Richard L. Street Jr.² and Ellen Peters³, ¹Medicine, Section of Rheumatology, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare System, New Haven, CT, ²Department of Communication, Texas A&M University, College Station, TX, ³Ohio State University, Columbus, OH
Background/Purpose: Numerous studies have found that Black patients are more risk averse than their White counterparts. In clinical practice, patients make judgments based on oral…
Abstract Number: 1313 • 2013 ACR/ARHP Annual Meeting
Tobacco Exposure Is Associated With Radiographic Damage In Hispanic and African American Rheumatoid Arthritis Patients
Rodolfo Perez Alamino¹, Luis R. Espinoza², Gail S. Kerr³, Christopher Swearingen⁴, Chunqiao Luo⁵, Yusuf Yazici⁶, Yvonne R. S. Sherrer⁷, Edward L. Treadwell⁸, Angelia D. Mosley-Williams⁹, Sharon Dowell¹⁰, Ignacio Garcia-Valladares¹¹, Theresa Lawrence-Ford¹², Adrian Godoy¹⁰, Akgun Ince¹³ and Cindy Flower¹⁴, ¹Rheumatology, Lousiana State University and LSU Medical Center, New Orleans, LA, ²Medicine-Section of Rheum, LSU Medical Center, New Orleans, LA, ³Rheumatology, Washington DC VAMC and Georgetown University and Howard University Hospital, Washington, DC, ⁴Pediatrics and Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR, ⁵Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, ⁶New York University Hospital for Joint Diseases, New York, NY, ⁷Rheum/Immunology, Centre Rheum Immunol Arthritis, Fort Lauderdale, FL, ⁸Dept Medicine Div of Rheum, East Carolina University, Greenville, NC, ⁹John Dingell VAMC, Detroit, MI, ¹⁰Division of Rheumatology, Howard University, Washington, DC, ¹¹Rheumatology, Guadalajara, Guadalajara, Mexico, ¹²North Georgia Rheumatology Group, PC, Lawrenceville, GA, ¹³Arthitis Consultants Inc, Saint Louis University, St. Louis, MO, ¹⁴Medicine, University of the West Indies, Bridgetown, Barbados
Background/Purpose: Although the etiology of rheumatoid arthritis (RA) is unknown, there are reported interactions of genetic and environmental factors. Tobacco exposure is a well-documented risk…
Abstract Number: 2102 • 2012 ACR/ARHP Annual Meeting
Patient Versus Physician Global Assessments in Ethnic Patients Wtih Rheumatoid Arthritis
Gail S. Kerr¹, Yusuf Yazici², Christopher J. Swearingen³, Luis R. Espinoza⁴, Edward L. Treadwell⁵, Yvonne R. S. Sherrer⁶, Angelia D. Mosley-Williams⁷, Akgun Ince⁸, Raj G. Nair⁹, Theresa Lawrence Ford¹⁰, Jeffrey Huang¹¹ and Carl A. Nunziato¹², ¹Rheumatology, Washington DC VAMC, Georgetown and Howard University, Washington, DC, ²New York University, New York, NY, ³Pediatric Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR, ⁴Medicine-Section of Rheum, Louisiana State University, New Orleans, LA, ⁵Dept Medicine Div of Rheum, East Carolina University, Greenville, NC, ⁶Rheum/Immunology, Centre Rheum Immunol Arthritis, Fort Lauderdale, FL, ⁷John Dingell VAMC, Detroit, MI, ⁸Arthitis Consultants Inc, Saint Louis University, St. Louis, MO, ⁹Rheumatology, Washington Hospital Center, Washington DC, DC, ¹⁰North Georgia Rheumatology, Lawrenceville, GA, ¹¹Rheumatology, Howard University Hospital, Washington, DC, ¹²Rheumatology, Washington DC VA and Howard University, Howard University Hospital, Washington, DC
Background/Purpose: Patient reported outcomes in rheumatoid arthritis (RA) are validated tools that assess disease status, are easily administered and used as components of RA composite…
Abstract Number: 1420 • 2012 ACR/ARHP Annual Meeting
Ethnicity and B Cell Depletion Therapy in Systemic Lupus Erythematosus
A. Lois-Iglesias¹, J. Ishorari² and D.A. Isenberg², ¹Rheumatology, University Hospital Ramón y Cajal, Madrid, Spain. University College London, London, United Kingdom, ²Centre for Rheumatology, University College London, London, United Kingdom
Background/Purpose:The aim of this study was to determine if there is any relation between ethnicity and outcome in patients with SLE treated with B cell…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].